What Does BPC-157 Stand For? The Story Behind “Body Protection Compound”
BPC-157 stands for "body protection compound 157." It is a 15-amino-acid peptide that a University of Zagreb team described in 1993 as the active fragment of a larger protein found in gastric juice. The 157 is part of the name, and the published papers don't say where the number comes from.
Where does the name "body protection compound" come from?
From a theory about the stomach. In 1993, Predrag Sikirić and colleagues in the pharmacology department of the University of Zagreb's medical faculty published "A new gastric juice peptide, BPC" in the Journal of Physiology, Paris. The paper described BPC as a protein with a molecular weight of about 40,000, recently isolated from gastric juice, and laid out what the authors called a stomach-stress-organoprotection hypothesis. They proposed it as a natural mediator of what they called organoprotection, and the name "body protection compound" fits that idea.
The group had already patented it. US Patent 5,288,708, filed in 1991 and granted on February 22, 1994, covers "pharmacologically active substance BPC" and its preparation from human or animal gastric juice.
What does the "157" in BPC-157 mean?
Nobody has documented it. The 1993 paper named a 15-amino-acid piece of the protein, thought to carry its activity, "BPC 157," and a 1994 rat study in Life Sciences called it "a 15 amino acid peptide BPC fragment." Neither paper explains the number.
It isn't the chain length, which is 15. It isn't the molar mass either, at 1419.56 g/mol. Later papers from the same group call it "stable gastric pentadecapeptide BPC 157," and pentadeca simply means fifteen. Any explanation beyond that is a guess.
What is BPC-157 made of?
Fifteen amino acids in one chain: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Note the three prolines in a row near the front. The peptide is synthetic, built in a lab to match the sequence the Zagreb group reported, and it also goes by the code PL-14736.
It is sold today as a freeze-dried peptide, with BPC-157 from Astral among the options, and buybpc157.org compares vendors by price per milligram.
How much is known about BPC-157?
Most of the work comes from the Zagreb group, which has published on BPC-157 since the 1990s, and almost all of it is in animals and cells. A 2025 systematic review in the HSS Journal, covering its use in orthopedic and sports medicine studies, found the evidence almost entirely preclinical. A phase 2 trial in acute hamstring strain, NCT07437547, is listed at Peking University Shenzhen Hospital and was recruiting as of November 2026.
What did the FDA panel decide in 2026?
On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6, with one abstention, to recommend adding BPC-157 to the list of bulk ingredients pharmacies may use in compounding. It was nominated for ulcerative colitis. The vote is advisory, and the FDA isn't bound by it. BPC-157 has no FDA approval as a drug.
Is BPC-157 banned in sport?
Yes. The World Anti-Doping Agency's 2022 Prohibited List named BPC-157 under S0, non-approved substances, the first time any substance had been listed by name as an example in that section.
FAQs
What does BPC stand for in BPC-157?
Body protection compound, the name the Zagreb group gave the gastric juice protein it came from.
Why is it called 157?
The papers don't say. The number doesn't match its length of 15 amino acids or its molar mass.
Is BPC-157 FDA approved?
No. An FDA advisory panel voted in July 2026 to recommend it for pharmacy compounding, and that vote doesn't bind the agency.
Sources
Sikirić P, et al. A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of Physiology, Paris, 1993.
Sikirić P, et al. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. Life Sciences, 1994.
- Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS Journal, 2025.
- Regulatory Affairs Professionals Society. FDA advisory committee backs two controversial peptides. Regulatory Focus, July 2026.
- World Anti-Doping Agency. 2022 Prohibited List: Summary of Major Modifications and Explanatory Notes.